Autopsy report · NCT02630394

A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease

“Principal Investigator has moved to another institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

University of Mississippi Medical Center

Sponsor type

University, hospital or other

Conditions

Sickle Cell Disease; Acute Chest Syndrome

Interventions

Azithromycin

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• A Study of Oral L-citrulline in Sickle Cell Disease
  “Principal Investigator moved to another institution” (98% match in meaning)
• Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
  “Principal Investigator has transferred to another Institution” (94% match in meaning)
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  “Principal Investigator has left the institution” (88% match in meaning)
• Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
  “Principal Investigator left institution” (87% match in meaning)
• State of Obesity Care in Canada Evaluation Registry
  “Principal Investigator left the institution” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.